Prostate Cancer Guide,prostate cancer signs

Hormone therapy in patients with large tumors of the prostate, causing the symptoms or the control of prostate cancer that has spread to lymph nodes or bones. The prostate is very small increases in childhood, but during puberty under the influence of testosterone, the male hormone, and a number of other hormones, including growth hormone and prolactin.

Hormone preparations are designed to stimulate reduce the effects of testosterone, the most important of all factors, the growth of prostate cancer.

produced only by understanding the complex actions of endocrine drugs, can be used to treat prostate cancer can be. All treatments will be the effects of testosterone in the tissue balance and do it in a variety of ways.

OrchiectomyOrchiectomy follows can be described as relatively simple and straightforward, but there are effective medical alternatives that no operation. Orchiectomy is performed under general or spinal anesthesia. This is a relatively fast. A total orchiectomy involves the removal of all testicular tissue, while a sub-total orchiectomy is the removal of hormones and equipment for the production of sperm from the testicles, the capsule can be behind the testicles.

There are two arguments for the orchiectomy for prostate cancer. The first argument is that a process is completed relatively quickly. Once done, the process can be forgotten and that the patient does not take drugs.

Another argument in favor of castration is that it is a  cost  method. In fact, the process is not cheap. It is usually performed when the patient is in hospital. The cost of orchiectomy 3000 is comparable to the lifetime costs of medical treatment for prostate cancer.

Another argument against is that if a patient takes pills in addition to orchiectomy, the survival can be prolonged, is a point, twice a day from the disease in addition to orchiectomy.

therapyOestrogens estrogens have been used to treat prostate cancer for over 60 years. The main estrogen in patients with prostate cancer is diethylstilbestrol administered. It is a synthetic female hormone. The treatment is generally considered as one tablet once or three times a day.

The effects of estrogen in the blood are too complicated. These changes include the formation of blood clots and thus water retention. to coagulate a result of this increased propensity and by fluid retention, increased blood pressure and patients who were taking estrogen are more prone to strokes and heart attacks. There is evidence that low doses of estrogen as effective as higher doses of the fight against prostate cancer. The side effects are similar, even with small doses and has in numerous studies that continue today confirmed.

Estrogens also have other effects. About 30% of patients were treated with estrogen, developed gastrointestinal very important. This is composed mainly of abdominal pain, wind and nausea. There are mood swings and all patients suffer from inflammation of the sinuses, which can be very delicate and very unpleasant.

There are so many other treatments for prostate cancer does not seem necessary today, patients are treated with female hormones.

Anti-androgens are androgensAnti drugs that act by blocking the binding of testosterone and dihydrotestosterone to androgen receptors. Among these drugs are flutamide and bicalutamide, also known as Drogenil and Casodex, and cyproterone acetate.

Flutamide has been introduced in the treatment of prostate cancer in the 1970s. response to treatment were said to be short-term and found that many patients with severe depression. Flutamide can cause side effects ranging in severity. The most common is diarrhea.
This occurs in 12% of patients. In rare cases, Flutamide cause liver damage. When this develops, then treatment should be discontinued. Very rarely, the side effects of flutamide in the liver to be that the results of death.

Bicalutamide in the treatment of prostate cancer were introduced in the 1980s. The introduction of this drug is important for patients with prostate cancer. It is important because it an effective treatment without significant side effects. It has been argued that bicalutamide can be used as the sole treatment for prostate cancer. Bicalutamide has the advantage that some patients remain in power despite treatment for prostate cancer.
About 50% of patients treated with bicalutamide monotherapy can get sexual potency.

Cyproterone acetate is a complex drug in their biochemical effects in the body. This can be fluid retention and use associated with an increased risk of stroke and heart attacks. You can also liver toxicity. For this reason, we recommend that cyproterone acetate is used only for a very short period and not to patients over a longer period. The Committee of the drug is not recommended for long term use of cyproterone acetate.

agonistsTreatment gonadotropin-releasing hormone with these drugs was originally developed by nasal spray or continuous intravenous administration. Later injections were subcutaneous and in 1980 half of the plans has been the treatment once a month. 3 months later developed treatments. The drug remains under the skin at the injection site and gradually spread into the bloodstream for a certain period so that the long-term suppression of male hormones.
LHRH agonists are effective and humane treatment of prostate cancer.

The most common side effects associated with the treatment of heat stress experienced by women during menopause. Hot flashes can be mild or severe, rare or very common. The treatment of hot flushes, other drugs such as clonidine and medroxyprogesterone acetate, which can cause problems, herbal remedies are rarely effective. Other side effects include anemia and oesteoporosis.

LHRH agonists in combination with anti-androgensIt proposed in the 1980s, there is not the testes are the only source of male hormones in the body are available, it is important to remove all sources of the male hormone. known from this point of the theory of total androgen blockade, even as the maximum androgen blockade.

The medical profession has used the term with great skepticism. The National Cancer Institute has launched a clinical trial to compare the treatment with an LHRH agonist alone or in combination with an anti-androgen. The results of this research were published in 1989. It has been shown that there is a clear survival benefit for combination therapy. The debate goes on, but a recent analysis published in 2000 confirmed the usefulness in the study by the National Cancer Institute demonstrated.

Intermittent hormonal TherapyIn an attempt to allow the return of power, was introduced the practice of giving medical treatment to temporarily. It is possible that this will be as effective as continuous treatment in the fight against prostate cancer, but nobody is sure about this. The department may return six months after stopping treatment. At this time, the PSA levels began to rise and the treatment should be restarted. This approach can be psychologically harmful.

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.